We currently do not have sufficient information about the CEO.
Key information
Gadi Levin
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
3yrs
CEO ownership
0.3%
Management average tenure
no data
Board average tenure
7yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Gadi Levin's remuneration changed compared to Vaxil Bio's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
CA$484k
Dec 31 2025
n/a
n/a
CA$521k
Sep 30 2025
n/a
n/a
-CA$94k
Jun 30 2025
n/a
n/a
-CA$110k
Mar 31 2025
n/a
n/a
-CA$142k
Dec 31 2024
n/a
n/a
-CA$130k
Sep 30 2024
n/a
n/a
-CA$104k
Jun 30 2024
n/a
n/a
-CA$96k
Mar 31 2024
n/a
n/a
-CA$187k
Dec 31 2023
CA$53k
CA$51k
-CA$254k
Sep 30 2023
n/a
n/a
-CA$453k
Jun 30 2023
n/a
n/a
-CA$564k
Mar 31 2023
n/a
n/a
-CA$583k
Dec 31 2022
CA$72k
CA$72k
-CA$584k
Sep 30 2022
n/a
n/a
-CA$691k
Jun 30 2022
n/a
n/a
-CA$791k
Mar 31 2022
n/a
n/a
-CA$854k
Dec 31 2021
CA$98k
CA$76k
-CA$986k
Sep 30 2021
n/a
n/a
-CA$1m
Jun 30 2021
n/a
n/a
-CA$1m
Mar 31 2021
n/a
n/a
-CA$1m
Dec 31 2020
CA$60k
CA$60k
-CA$1m
Sep 30 2020
n/a
n/a
-CA$1m
Jun 30 2020
n/a
n/a
-CA$1m
Mar 31 2020
n/a
n/a
-CA$1m
Dec 31 2019
CA$60k
CA$60k
-CA$1m
Compensation vs Market: Insufficient data to establish whether Gadi's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Gadi's compensation has been consistent with company performance over the past year.
CEO
Gadi Levin (53 yo)
3yrs
Tenure
CA$53,000
Compensation
Mr. Gadi Levin, CPA, MBA, CA (SA), B.Com, serves as Chairman and Chief Executive Officer since July 31, 2023 at Vaxil Bio Ltd. Mr. Levin is CFO & Corporate Secretary of Eshbal Functional Food Inc. from Apr...
Board Members
Name
Position
Tenure
Compensation
Ownership
Gadi Levin
CEO & Chairman
9.8yrs
CA$53.00k
0.33% $ 1.4k
Riva Kovjazin
Senior Scientist & Member of Scientific Advisory Board
no data
no data
no data
Michael Berelowitz
Special Advisor to the Board
5.4yrs
no data
no data
Ari Kellen
Member of Scientific Advisory Board
8.6yrs
no data
2.78% $ 12.1k
Shawn Langer
Independent Member of Scientific Advisory Board
8.6yrs
no data
2.5% $ 10.9k
Daniel Bloch
Independent Director
3.3yrs
no data
no data
Simon Igelman
Director
less than a year
no data
no data
7.0yrs
Average Tenure
63yo
Average Age
Experienced Board: VXLL.F's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/13 12:02
End of Day Share Price
2026/07/06 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vaxil Bio Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.